Google
BJDX — BLUEJAY DIAGNOSTICS INC (Healthcare >> Medical Devices)
BJDX FAQ
What is BJDX's ROE?
BLUEJAY DIAGNOSTICS INC reports a Return on Equity (ROE) of -165.10%.
What is BJDX's dividend yield?
BLUEJAY DIAGNOSTICS INC offers a dividend yield of 0.00%.
What is BJDX's Deepscope Quality Score?
Deepscope rates BJDX's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BJDX?
Deepscope's AI Timing Score for BJDX is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BJDX belong to?
BLUEJAY DIAGNOSTICS INC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 5.23
Price
0.43
(8.96%)
Day Change
|
|
|---|
BJDX, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 87 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.23 |
| PBV / Sector |
1.27 / 7.41
GOOD
|
| Earning Per Share | -6.80 |
| PE / Sector |
N/A / 28.89
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
17.23 M
GREAT
|
| Average 1W Daily Value |
68.56 M
|
| Timing Factors |
|
85% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
43% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-06-09 09:39:42 |
| Symbol | BJDX |
| Name | BLUEJAY DIAGNOSTICS INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 1.03 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 5.31 / 18,405.70 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 360 Massachusetts Avenue, Acton, MA, United States, 01720
Phone: 844 327 7078
Website: https://bluejaydx.com
Sector: Healthcare >> Medical Devices
Description: Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
